Patent details
EP4340842 Title: SOTORASIB FOR USE IN THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP4340842
- PCT Application Number:
- US2022029677
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP227299252
- PCT Publication Number:
- WO2022245857
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SOTORASIB FOR USE IN THE TREATMENT OF CANCER
- French Title of Invention:
- SOTORASIB POUR UTILISATION DANS LE TRAITEMENT DU CANCER
- German Title of Invention:
- SOTORASIB ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 17/05/2022
- Grant date:
- 27/08/2025
- EP Publication Date:
- 27/03/2024
- PCT Publication Date:
- 24/11/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/08/2025
- EP B1 Publication Date:
- 27/08/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/05/2042
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/08/2025
- Name:
- Amgen Inc.
- Address:
- One Amgen Center Drive, Thousand Oaks, California 91320, United States (US)
Inventor
1
- Name:
- DUTTA, Sandeep
- Address:
- United States (US)
2
- Name:
- HOUK, Brett E.
- Address:
- United States (US)
3
- Name:
- FRIBERG, Gregory
- Address:
- United States (US)
4
- Name:
- PARK, Joseph
- Address:
- United States (US)
5
- Name:
- HENARY, Haby
- Address:
- United States (US)
6
- Name:
- MATHER, Omar
- Address:
- United States (US)
7
- Name:
- NGARMCHAMNANRITH, Gataree
- Address:
- United States (US)
Priority
- Priority Number:
- 202163190061 P
- Priority Date:
- 18/05/2021
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/519; A61P 35/00; A61P 35/04;
Publication
European Patent Bulletin
- Issue number:
- 202535
- Publication date:
- 27/08/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 01/06/2026
- Annual Fee Number:
- 5
- Annual Fee Amount:
- 52 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|